Search for: "Mylan, Inc." Results 21 - 40 of 672
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
28 Oct 2016, 2:35 pm by Laura Ray
Mylan N.V. recently “announced that its subsidiary, Mylan Inc., has agreed to the terms of a $465 million settlement with the U.S. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
10 Feb 2014, 8:37 am
Mylan Inc., the patch had to be defined under the state's product liability law as it pertains to drug manufacturers. [read post]
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
17 Dec 2010, 7:47 am by Lawrence B. Ebert
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
21 Oct 2009, 6:08 pm by mcarzima@imediainc.com
Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales from 2000 to 2004. [read post]
21 Oct 2009, 6:08 pm
Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales from 2000 to 2004. [read post]
9 Apr 2017, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit returned to its consideration of the outcome in the District Court of The Medicines Company's ANDA litigation against Mylan and Bioniche Pharma over a proposed generic version of Medicines' bivalirudin drug (sold as Angiomax®), an anticoagulant used in heart surgery. [read post]
31 Dec 2010, 2:46 am by Bob Kraft
The  drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]